Top searches



B2RLaw advises SaaS-enabled B2B marketplace for the healthcare industry, Dentametr, on a pre-seed round with investors, which includes Octopus Ventures


B2RLaw has advised Dentametr and its founders on its pre-seed round capital raise with investors including leading investment fund Octopus Ventures, and a number of angel investors.

Dentametr is a SaaS-enabled B2B marketplace for the healthcare industry currently focusing on the dental services market in Poland. Its main product manages procurement of supplies, tools and equipment for dental clinics through a proprietary platform as well as optimizes their inventory management. The Company was founded by Mateusz Gawałkiewicz and Rafał Tuziak.

Octopus Ventures is a multi-stage European venture capital investor specializing in health, fintech, deep tech, B2B software and consumer. It is one of Europe’s largest and most active venture capital investors with offices in London and New York. Its specialist investment teams deploy more than GBP 200 million ever year, from Seed to Series B. Octopus Ventures is part of the Octopus Group.

As well as Octopus Ventures, a group of angel investors took part in the round, including a group of C-level executives in the healthcare industry, experienced entrepreneurs, lawyers, and management consultants.

Teresa Pilecka–Juda (Attorney-at-law, Senior Associate) provided advice to Dentametr, overseen by Rafał Stroiński (Advocate, Senior Partner).

Teresa advises, “It has been a pleasure to support the Dentametr team on this transaction, which has allowed this Polish company to obtain capital for its further growth. The fact that well-regarded international fund Octopus Ventures has invested into Dentametr is testament to the fact that the Company has an exciting future.

View more resources

Catch up on the very latest B2RLAW
announcements and news here.


Bartłomiej Jankowski recommended in the Chambers & Partners ranking 2023

We are proud to announce that in this year’s edition of Chambers & Partners Europe Guide 2023 our Senior Partner […]


B2RLaw advises Graham Partners on its acquisition of Taoglas

B2RLaw has advised Graham Partners, a private investment firm targeting technology-driven advanced manufacturing companies, on Polish aspects of its acquisition […]


B2RLaw advises Moffitt Cancer Center and OncoBay Clinical in a PLN 150 million investment in OncoBay by Clinscience

B2RLaw has advised Moffitt Cancer Center and OncoBay Clinical, one of its for-profit subsidiaries, in an investment in OncoBay by […]


B2RLaw advises Polish unicorn DocPlanner on its acquisition of MyDr

B2RLaw has advised Polish unicorn DocPlanner on its acquisition of MyDr – DocPlanner’s first acquisition on the Polish market. Docplanner […]


New Compliance 360 practice at B2RLaw

B2RLaw has established a multidisciplinary team whose aim is to support clients in monitoring and adapting their activities to the […]


B2RLaw advises on the sale of award-winning Gdynia office complex

B2RLaw has advised the sellers (a Dutch company and Polish companies) on the sale of Łużycka Office Park (buildings A, […]


Get in touch

Not sure who to contact? Let us help you find the right lawyer.

This site uses cookies to improve your experience More information.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.